methylphenidate has been researched along with Fetal Growth Restriction in 2 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report the effects of intravenous abuse of pentazocine hydrochloride and methylphenidate hydrochloride during pregnancy." | 7.68 | Intravenous pentazocine and methylphenidate abuse during pregnancy. Maternal lifestyle and infant outcome. ( Casiro, OG; Debooy, VD; Seshia, MM; Tenenbein, M, 1993) |
| " Women who received amphetamine-dextroamphetamine or methylphenidate monotherapy in the first half of pregnancy were compared with unexposed women." | 3.85 | Placental Complications Associated With Psychostimulant Use in Pregnancy. ( Bateman, BT; Cohen, JM; Desai, RJ; Gray, KJ; Hernández-Díaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E, 2017) |
| "To report the effects of intravenous abuse of pentazocine hydrochloride and methylphenidate hydrochloride during pregnancy." | 3.68 | Intravenous pentazocine and methylphenidate abuse during pregnancy. Maternal lifestyle and infant outcome. ( Casiro, OG; Debooy, VD; Seshia, MM; Tenenbein, M, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, JM | 1 |
| Hernández-Díaz, S | 1 |
| Bateman, BT | 1 |
| Park, Y | 1 |
| Desai, RJ | 1 |
| Gray, KJ | 1 |
| Patorno, E | 1 |
| Mogun, H | 1 |
| Huybrechts, KF | 1 |
| Debooy, VD | 1 |
| Seshia, MM | 1 |
| Tenenbein, M | 1 |
| Casiro, OG | 1 |
2 other studies available for methylphenidate and Fetal Growth Restriction
| Article | Year |
|---|---|
Placental Complications Associated With Psychostimulant Use in Pregnancy.
Topics: Abruptio Placentae; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Att | 2017 |
Intravenous pentazocine and methylphenidate abuse during pregnancy. Maternal lifestyle and infant outcome.
Topics: Adolescent; Adult; Developmental Disabilities; Female; Fetal Growth Retardation; Follow-Up Studies; | 1993 |